当前位置: X-MOL首页全球导师 国内导师 › 徐峰

个人简介

浙江大学科学博士(呼吸病学),德国吕贝克大学医学博士(呼吸病学),美国加州大学洛杉矶分校博士后(感染免疫学)。现为浙江大学医学院附属二院感染性疾病科副主任,主任医师,博士生导师,浙江大学医学院医学八年制2012级1班和2014级2班班主任。担任中华医学会呼吸病学分会感染学组委员,中华医学会科学普及分会青年委员,浙江省医学会热带病和寄生虫病分会副主任委员,浙江省医学会呼吸病学分会感染学组委员,浙江省临床免疫分会委员,浙江省预防医学会出生缺陷防控分会委员,J Trans Med (IF: 3.99)杂志编委。是Ann Intern Med(IF:17.81)等17种SCI期刊的审稿人。

研究领域

呼吸病学、感染病学 肺部细菌感染免疫;急性肺损伤发病机制。

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

1.Qian J, Hu Y, Zhao LF, Hong ZP,Xia JY, Shi LY, Xu F*. Protective role of ADSCs on S. aureus-induced lung injury is mediated by secretion. Stem Cells, 2016, Feb 11. doi: 10.1002/stem.2337. [Epub ahead of print]. 2.Liu JL, Wu XJ, Lu F, Zhao LF, Shi LX, Xu F*. Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia. Sci Rep, 2016, 6: 22271. 3.Liu JL#, Xu F*, Zhou H, Wu XJ, Shi LX, Lu RQ, Farcomeni A, Venditti M, Zhao YL, Luo SY, Dong XJ, Falcone M. Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency. Sci Rep, 2016; 6: 22911. 4.Xu F, Kang Y, Zhuang N, Lu Z, Zhang H, Xu D, Ding Y, Yin H, Shi L*. Bcl6 sets a threshold for antiviral signaling by restraining IRF7 transcriptional program. Sci Rep. 2016; 6: 18778. 5.Wang S, Zheng G, Zhao L, Xu F*, Qian J*. Shp-2 contributes to anti-RSV activity in human pulmonary alveolar epithelial cells by interfering with the IFN-α-induced Jak/Stat1 pathway. J Cell Mol Med, 2015, 19(10): 2432-40. 6.Ying H, Kang Y, Zhan H, Zhao D, Xia J, Lu Z, Wang H, Xu F*, Shi L*. MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway. J Immunol, 2015; 194(3): 1239-51. 7. Xu F, Diao R, Liu J, Kang Y, Wang X, Shi L*. Curcumin attenuates staphylococcus aureus-induced acute lung injury. Clin Respir J, 2015; 9(1): 87-97. 8.Song YL, Xu F (co-first author), Seeley E, Ou J, Zhu XD, Sun RJ*, Bai CX*. Acute lung injury and respiratory distress syndrome: emerging research in China. Am J Respir Crit Care Med, 2014, 190(10): 1090-1093. 9.Wu X, Xu F*. Dendritic cells during Staphylococcus aureus infection: subsets and roles. J Transl Med, 2014; 12: 358. 10.Zhao L#, Xia J#, Wang X, Xu F*. Transcriptional regulation of CCL20 expression. Microbes Infect, 2014; 16(10): 864-70. 11.Xia J#, Shi L#, Zhao L, Xu F*. Impact of vitamin D supplementation on outcomes of tuberculosis: a systematic review and meta-analysis of randomized controlled trials. Chin Med J, 2014; 127 (17): 3127-34. 12. Xu F, Kang Y, Zhang H, Piao Z, Yin H, Diao R, Xia J, Shi L*. Akt1-mediated regulation of macrophage polarization in a murine model of Staphylococcus aureus pulmonary infection. J Infect Dis, 2013; 208(3): 528-538. 13. Xu F*, Hu Y, Zhou J, Wang X*. Mesenchymal stem cells in acute lung injury: are they ready for translational medicine? J Cell Mol Med, 2013; 17(8): 927-935. 14. Xu F, Cheng Y, Diao R, Zhou X, Wang X, Ma Y, Lv W, Shen H*. Sarcoidosis: vaginal wall and vulvar involvement. Sarcoidosis Vasc Diffuse Lung Dis, 2012; 29(2): 151-154. 15.Tian XL, Xu F (co-first author), Lung WY, Meyerson C, Ghaffari AA, Cheng GH, Deng JC*. Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria. PLoS ONE, 2012; 7(9): e41879. 16. Yang Y, Xu F*, Shi LY, Daio R, Cheng XY, Jing JY, Wang XD, Shen HH. The efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China. Chin Med J (Engl), 2012; 125(4): 639-645. 17. Cheng YS, Xu F*. Anti-cancer function of polyinosinic-polycytidylic acid. Cancer Bio & Ther, 2010; 10(12): 1219-1223. 18.Xia JY, Chen XY, Xu F*, Yang Y, Wang HY, Xue J. A case report of systemic lupus erythematosus combined with Castleman's disease and literature review. Rheumatol Int, 2012; 32(7): 2189-2193. 19.Chen XY, Xu F*, Xia JY, Cheng YS, Yang Y. Bacteremia due to Rhodococcus equi: a case report and review of the literature. J Zhejiang Univ Sci, 2009; 10(12): 933-936.

推荐链接
down
wechat
bug